Immunoglobulin Fusion Proteins as a Tool for Evaluation of T-Cell Costimulatory Molecules
- 1 January 2002
- journal article
- research article
- Published by Springer Nature in Molecular Biotechnology
- Vol. 21 (3) , 259-264
- https://doi.org/10.1385/mb:21:3:259
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Induction of therapeutic T-cell immunity by tumor targeting with soluble recombinant B7-immunoglobulin costimulatory molecules.1999
- New Goals for the U.S. Human Genome Project: 1998-2003Science, 1998
- Immunological ignorance of silent antigens as an explanation of tumor evasionImmunology Today, 1998
- Artificial cell surface constructs for studying receptor–ligand contributions to lymphocyte activationJournal of Immunological Methods, 1997
- Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinomaHepatology, 1997
- Effective tumor vaccines generated by in vitro modification of tumor cells with cytokines and bispecific monoclonal antibodiesNature Medicine, 1997
- Costimulation and its role in organ transplantationClinical Transplantation, 1996
- Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse.The Journal of Experimental Medicine, 1995
- Effective Tumor Vaccine Generated by Fusion of Hepatoma Cells with Activated B CellsScience, 1994
- Costimulation of T cells for tumor immunityImmunology Today, 1993